Prevalence, Risk Factors and Outcomes Associated with Acute Kidney Injury in Patients Hospitalized for COVID-19: A Comparative Study between Diabetic and Nondiabetic Patients

Table 2

Medications used by patients during hospitalization.

Medication	Total	Diabetes	Nondiabetes	value
Statins	66 (26.0)	43 (33.9)	23 (18.1)	0.004
ACEI/ARB	79 (31.1)	54 (42.5)	25 (19.7)	<0.001
Diuretics	24 (9.4)	15 (11.8)	9 (7.1)	0.20
CCB	20 (7.9)	12 (9.4)	8 (6.3)	0.35
Clopidogrel	15 (5.9)	12 (9.4)	3 (2.4)	0.02
Aspirin (ASA)	27 (10.6)	15 (11.8)	12 (9.4)	0.54
Warfarin	4 (1.6)	4 (3.1)	—	0.12
Heparin	252 (99.2)	125 (98.4)	127 (100.0)	1.00
Enoxaparin	2 (0.8)	2 (1.6)	—	0.50

ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker; CCB: calcium channel blocker.